DOD Biotech PCL (BKK:DOD)

DOD Biotech PCL Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	223.09	67.99	30.27	161.68	143
Cash & Short-Term Investments	223.09	67.99	30.27	161.68	143
Cash Growth	228.12%	124.62%	-81.28%	13.06%	73.51%
Accounts Receivable	24.37	82.29	39.05	315.37	263.19
Other Receivables	17.74	29.26	17.69	22.07	8.19
Receivables	42.1	111.55	56.74	337.44	271.38
Inventory	126.88	150.4	98.03	113.46	246.33
Other Current Assets	224.48	42.01	12.09	13.42	12.71
Total Current Assets	616.55	371.96	197.13	626	673.42
Property, Plant & Equipment	511.33	915.83	963	961.03	875.76
Long-Term Investments	2.6	2.6	2.6	2.6	105.71
Goodwill	0.25	0.25	-	-	-
Other Intangible Assets	43.06	50.48	5.57	5.66	11.44
Long-Term Deferred Tax Assets	95.5	90.64	92.54	7.9	26.53
Other Long-Term Assets	17.02	25.89	30.08	23.8	64.72
Total Assets	1,286	1,458	1,291	1,627	1,758
Accounts Payable	39.23	75.4	80.44	93.09	181.14
Accrued Expenses	22.5	25.25	17.17	13.64	31.9
Short-Term Debt	45	110.49	148.7	77	130.39
Current Portion of Long-Term Debt	-	2.12	19.81	28.76	39.58
Current Portion of Leases	0.77	2.8	2.62	4.92	8.34
Current Income Taxes Payable	1.72	21.18	1.66	-	25.32
Other Current Liabilities	256.76	45.55	33.71	41.74	51.83
Total Current Liabilities	365.98	282.8	304.11	259.16	468.5
Long-Term Debt	-	-	2.12	19.31	22.28
Long-Term Leases	0.29	53.29	55.82	53.31	4.56
Long-Term Deferred Tax Liabilities	10.95	18.49	10.68	12.05	24.1
Other Long-Term Liabilities	6.6	12.29	16.87	15.5	8.17
Total Liabilities	394.4	377.58	397.29	364.7	532.66
Common Stock	225.21	225.21	205	205	205
Additional Paid-In Capital	947.27	1,051	890.85	890.85	939.87
Retained Earnings	-273.87	-225.16	-233.86	164.47	50.97
Comprehensive Income & Other	-	7.35	25.17	20.24	18.22
Total Common Equity	898.6	1,058	887.15	1,281	1,214
Minority Interest	-6.69	22.12	6.48	-18.26	10.87
Shareholders' Equity	891.91	1,080	893.63	1,262	1,225
Total Liabilities & Equity	1,286	1,458	1,291	1,627	1,758
Total Debt	46.06	168.69	229.08	183.3	205.15
Net Cash (Debt)	177.03	-100.7	-198.81	-21.62	-62.15
Net Cash Per Share	0.39	-0.23	-0.48	-0.05	-0.15
Filing Date Shares Outstanding	450.41	450.41	410	410	410
Total Common Shares Outstanding	450.41	450.41	410	410	410
Working Capital	250.58	89.16	-106.98	366.85	204.93
Book Value Per Share	2.00	2.35	2.16	3.12	2.96
Tangible Book Value	855.29	1,007	881.58	1,275	1,203
Tangible Book Value Per Share	1.90	2.24	2.15	3.11	2.93
Land	153.48	218.87	218.87	218.87	220.57
Buildings	330.42	629.76	535.29	482.56	500.3
Machinery	199.85	297.4	275.58	228.29	272.82
Construction In Progress	26.62	13.71	109.92	159.25	22.27

Updated Feb 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.